日本語
 
Help Privacy Policy ポリシー/免責事項
  詳細検索ブラウズ

アイテム詳細

  Generalized anxiety disorder: Prevalence, burden, and cost to society

Wittchen, H. (2002). Generalized anxiety disorder: Prevalence, burden, and cost to society. Depression and Anxiety, 16(4), 162-171.

Item is

基本情報

表示: 非表示:
資料種別: 学術論文
その他のタイトル : Depress. Anxiety

ファイル

表示: ファイル

関連URL

表示:

作成者

表示:
非表示:
 作成者:
Wittchen, HU1, 著者
所属:
1Max Planck Institute of Psychiatry, Max Planck Society, ou_1607137              

内容説明

表示:
非表示:
キーワード: generalized anxiety disorder; prevalence; health care utilization; comorbidity
 要旨: Generalized anxiety disorder (GAD) is a prevalent and disabling disorder characterized by persistent worrying, anxiety symptoms, and tension. It is the most frequent anxiety disorder in primary care, being present in 22% of primary care patients who complain of anxiety problems. The high prevalence rate of GAD in primary care (8%) compared to that reported in the general population (12-month prevalence 1.9-5.1%) suggests that GAD patients are high users of primary care resources. GAD affects women more frequently than men and prevalence rates are high in midlife (prevalence in females over age 35: 10%) and older subjects but relatively low in adolescents. The natural course of GAD can be characterized as chronic with few complete remissions, a waxing and waning course of GAD symptoms, and the occurrence of substantial comorbidity particularly with depression. Patients with GAD demonstrate a considerable degree of impairment and disability, even in its pure form, uncomplicated by depression or other mental disorders. The degree of impairment is similar to that of cases with major depression. GAD comorbid with depression usually reveals considerably higher numbers of disability days in the past month than either condition in its pure form. As a result, GAD is associated with a significant economic burden owing to decreased work productivity and increased use of health care services, particularly primary health care. The appropriate use of psychological treatments and antidepressants may improve both anxiety and depression symptoms and may also play a role in preventing comorbid major depression in GAD thus reducing the burden on both the individual and society. (C) 2002 Wiley- Liss, In

資料詳細

表示:
非表示:
言語: eng - English
 日付: 2002
 出版の状態: 出版
 ページ: -
 出版情報: -
 目次: -
 査読: 査読あり
 識別子(DOI, ISBNなど): eDoc: 4023
ISI: 000180131800004
 学位: -

関連イベント

表示:

訴訟

表示:

Project information

表示:

出版物 1

表示:
非表示:
出版物名: Depression and Anxiety
  出版物の別名 : Depress. Anxiety
種別: 学術雑誌
 著者・編者:
所属:
出版社, 出版地: -
ページ: - 巻号: 16 (4) 通巻号: - 開始・終了ページ: 162 - 171 識別子(ISBN, ISSN, DOIなど): ISSN: 1091-4269